Farhad Faridhosseini

Farhad Faridhosseini

Auto-generated profile, based on publicly available information

Farhad Faridhosseini

Psychiatry and Behavioral Sciences Research Center and Department of Psychiatry, School of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 February 2021 in The Journal of Maternal-Fetal & Neonatal Medicine
Verified
Journal Article
Closed access
SASedigheh Abdollahpour
Sedigheh Abdollahpour
AHAbbas Heydari
Abbas Heydari
HEHosein Ebrahimipour
Hosein Ebrahimipour
FFFarhad Faridhoseini
Farhad Faridhoseini
HMHamid Heidarian Miri
Hamid Heidarian Miri
TKTalat Khadivzadeh
Talat Khadivzadeh
Postpartum depression (PPD) is one of the psychological complications of mothers who have experienced severe maternal morbidity/maternal near miss (SMM/MNM) which can adversely affect the wellbeing...

26 October 2020 in Journal of Psychosomatic Obstetrics & Gynecology
Verified
Journal Article
Closed access
SASedigheh Abdollahpour
Sedigheh Abdollahpour
AHAbbas Heydari
Abbas Heydari
HEHosein Ebrahimipour
Hosein Ebrahimipour
FFFarhad Faridhoseini
Farhad Faridhoseini
TKTalat Khadivzadeh
Talat Khadivzadeh
Maternal near miss (MNM) refers to women who survive death as a result of life-threatening obstetric complications or organ system dysfunction during pregnancy, childbirth or postpartum. The aim of...

10 January 2022 in Reproductive Health
Verified
Journal Article
Open access
PDF file
SASedigheh Abdollahpour
Sedigheh Abdollahpour
AHAbbas Heydari
Abbas Heydari
HEHosein Ebrahimipour
Hosein Ebrahimipour
FFFarhad Faridhoseini
Farhad Faridhoseini
TKTalat Khadivzadeh
Talat Khadivzadeh
Background: A Near Miss Mother (NMM) who survives life-threatening conditions, experiences intense physical, emotional, and psychological consequences following the maternal near-miss (MNM) events. The aim of this study was therefore to explore indepth understanding meaning of NMM everyday lived experiences on the social and cultural background of Iran. Methods: This qualitative study utilized a hermeneutic phenomenology procedure. The study was conducted in hospitals affiliated with the Educational, Research and Treatment Centerwhich usually handle the NMMs. The sampling was purposeful with a maximum variation of eleven NMMs. Datawere collected using unstructured face-to-face interviews, and thetranscribed data were analyzed using Diekelmann, Allen, and Tanner’s seven-stage thematic analysis approach. Results: "Death-stricken survivor mother" was the central emerged theme, and three extracted sub-themes included: "Distorted psyche on a journey to death", "physical destruction due to an ominous event ", and the "vicissitudinous life after reviving ". These sub-themes, in turn, involved 12 sub-themes that emerged from 38 common meanings and 1200 codes. Conclusions: Findings demonstrate that the living conditions of NMMs are mixed in all aspects of the MNM event. They need a supportive program that includes additional follow-up visits, psychological support from the time of hospitalization until long-time after discharge, alleviation of social, sexual, and financial worries to return them to the normal life, as well as psychosocial rehabilitation to increase their life quality. Furthermore, post-discharge care in NMMs should be done actively and directly at their homes.

1 July 2021 in Basic and Clinical Neuroscience Journal
Verified
Journal Article
Open access
PDF file
NSNajmeh Shahini
Najmeh Shahini
ATAli Talaei
Ali Talaei
MSMohammadreza Shalbafan
Mohammadreza Shalbafan
FFFarhad Faridhosseini
Farhad Faridhosseini
MZMalihe Ziaee
Malihe Ziaee
Introduction: Inflammatory processes in the brain play an important role in the etiopathogenesis of Obsessive-Compulsive Disorder (OCD). Cyclooxygenase inhibitors, such as celecoxib reduce the production of proinflammatory cytokines. This double-blind study aimed to investigate the effects of adding celecoxib to Selective Serotonin Reuptake Inhibitors (SSRIs)on treating OCD. Methods: Sixty patients who met the diagnosis criteria for OCD based on the Diagnostic and Statistical Manual of Mental Disorders -Fourth Edition- Text Revision (DSM-IV-TR) were recruited in the present study. Two psychiatrists independently confirmed the diagnosis by performing structured interviews. The study participants included 23 patients who received SSRIs and celecoxib (400 mg twice daily) and 22 patients in the control group that received SSRIs and placebo. Moreover, at baseline, in weeks 4, 8, and 12, the explored patients were assessed by a psychiatrist using the Yale-Brown Obsessive-Compulsive Scale (Y-BCOS). Results: A significant difference was observed in the change of scores on the Y-BOCS in week 12, compared with the onset of the study between the study groups (t= -8.976, df=38, P=0.001). There was a significant difference between the study groups in obsession (F= 49.19, df= 1, P≤0.001), compulsion (F= 13.78, df= 1, P= 0.001), and OCD (F= 57.25, df= 1, P≤0.001), i.e., higher in the celecoxib group. Conclusion: This study showed that adjuvant treatment with celecoxib can further improve the symptoms of OCD in individuals receiving SSRIs.

5 December 2015 in Iranian Red Crescent Medical Journal
Verified
Journal Article
Open access
PDF file
AZAlireza Zahiroddin
Alireza Zahiroddin
FFFarhad Faridhosseini
Farhad Faridhosseini
AZAzar Zamani
Azar Zamani
NSNajmeh Shahini
Najmeh Shahini
Background: Antidepressant-induced sexual dysfunction (SD) is a common problem, associated with a significant risk of non-adherence. Selective Serotonin Reuptake Inhibitors (SSRIs) are associated with a substantial risk of SD. Only 10 % of patients show spontaneous improvement during follow up period. Objectives: This study aimed to compare two proposed medication (bupropion vs. amantadine) in alleviating SD in patients treated with SSRIs. Patients and Methods: In a randomized, single-blinded, clinical trial in Iran, 46 patients were recruited based on DSM-IV-TR criteria and semi-structured interview. Then, they were randomized into two treatment groups using table of random numbers. Eight patients were excluded and finally 38 patients completed the study which lasted for 4 weeks. Twenty patients were given bupropion, 18 patients were randomly assigned to another group, and given amantadine. Patients were assessed with the Arizona sexual experience scale (ASEX) at baseline and 4 weeks after the treatment. Results: A total of 38 patients completed the study (18 patients in amantadine vs. 20 patients in bupropion).The mean ASEX scores gradually declined in both study groups during the trial. The reduction of ASEX score in bupropion group was more than that of amantadine group that was statistically significant. So, the addition of bupropion at higher doses appears to be more effective approach in comparison with amantadine. Conclusions: These results provide empirical support for conducting a further study on comparing different add-on strategies for treating drug-induced SD. Keywords: SSRIs; Sexual Dysfunction; Bupropion; Amantadine

23 December 2015 in Iranian Journal of Psychiatry and Behavioral Sciences
Verified
Journal Article
Open access
PDF file
SASeyed Mehdi Samimi Ardestani
Seyed Mehdi Samimi Ardestani
FFFarhad Faridhosseini
Farhad Faridhosseini
FSFatemeh Shirkhani
Fatemeh Shirkhani
AKArdeshir Karamad
Ardeshir Karamad
LFLayla Farid
Layla Farid
AMAli Motlagh
Ali Motlagh
Background: There are important differences regarding cancer disclosure in various geographical populations (Europeans, Western Asia, Eastern Asia), depending on multiple sociocultural factors, and therefore, there is no standard protocol on this issue, especially in Iran. Objectives: To evaluate the amount of information that Iranian patients have and their preference for the disclosure of the cancer diagnosis. Patients and Methods: In this cross sectional descriptive research, patients admitted in the oncology departments of 3 referral medical centers, Imam Hussein, Shohada-e-Tajrish and Modarres, in Tehran, from March 2007 to April 2008, were questioned about their awareness and knowledge regarding their diagnosis. Two different structured questionnaires were designed for the people who know and who didn't know their diagnosis. For the former, the survey concerned their psychological reactions to their situations, whether they would prefer to know about their diagnosis and by whom they are preferred to be informed .For the latter, the questionnaire included their preference whether to know the diagnosis and their current emotional state. Descriptive statistics and chi square test was applied to analyze gathering Data, using SPSS version 14. Results: 60.3% of the patients knew their diagnosis. Among the subjects who did not know their diagnosis, 88% preferred to be more informed about their diagnosis and 68% had some psychological reaction to their situations. Among the subjects who knew their diagnosis, 92.1 % preferred to know their diagnosis, 73.6% preferred to be informed directly by their physicians. Following the diagnostic disclosure, 81.5% reported that they had felt nervous, anxious and worried. Conclusions: The majority of Iranian patients with malignancy want to know the truth and they prefer to be informed directly by their doctors. Keywords: Diagnostic; Disclosure; Neoplasms; Doctor-Patient Relations; Patient Preference